Cargando…

The joint effects of apolipoprotein B, apolipoprotein A(1), LDL cholesterol, and HDL cholesterol on risk: 3510 cases of acute myocardial infarction and 9805 controls†

AIMS: Plasma levels of apolipoprotein B (apoB), the main surface protein on LDL particles, and LDL-C, the amount of cholesterol in those particles, are closely correlated and, considered separately, are positive risk factors. Plasma levels of apolipoprotein A(1), the main surface protein on HDL part...

Descripción completa

Detalles Bibliográficos
Autores principales: Parish, Sarah, Peto, Richard, Palmer, Alison, Clarke, Robert, Lewington, Sarah, Offer, Alison, Whitlock, Gary, Clark, Sarah, Youngman, Linda, Sleight, Peter, Collins, Rory
Formato: Texto
Lenguaje:English
Publicado: Oxford University Press 2009
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2735728/
https://www.ncbi.nlm.nih.gov/pubmed/19520708
http://dx.doi.org/10.1093/eurheartj/ehp221
_version_ 1782171274672340992
author Parish, Sarah
Peto, Richard
Palmer, Alison
Clarke, Robert
Lewington, Sarah
Offer, Alison
Whitlock, Gary
Clark, Sarah
Youngman, Linda
Sleight, Peter
Collins, Rory
author_facet Parish, Sarah
Peto, Richard
Palmer, Alison
Clarke, Robert
Lewington, Sarah
Offer, Alison
Whitlock, Gary
Clark, Sarah
Youngman, Linda
Sleight, Peter
Collins, Rory
author_sort Parish, Sarah
collection PubMed
description AIMS: Plasma levels of apolipoprotein B (apoB), the main surface protein on LDL particles, and LDL-C, the amount of cholesterol in those particles, are closely correlated and, considered separately, are positive risk factors. Plasma levels of apolipoprotein A(1), the main surface protein on HDL particles, and HDL-C, the amount of cholesterol in those particles, are also closely correlated with each other and, considered separately, are negative risk factors. The interdependence of these four risk factors is unclear. METHODS AND RESULTS: Case–control study among 3510 acute myocardial infarction patients (without prior vascular disease, diabetes, or statin use) in UK hospitals and 9805 controls. Relative risks (age, sex, smoking, and obesity-adjusted) were more strongly related to apoB than to LDL-C and, given apoB, more strongly negatively related to apoA(1) than to HDL-C. The ratio apoB/apoA(1) was uncorrelated with time since symptom onset in cases, was reproducible in samples collected a few years apart in controls (correlation 0.81), and encapsulated almost all the predictive power of these four measurements. Its effect was continuous, substantial throughout the UK normal range [relative risk, top vs. bottom decile of this ratio, 7.3 (95% CI 5.8–9.2)] and varied little with age. The ratio apoB/apoA(1) was substantially more informative about risk (χ(1)(2) = 550) than were commonly used measures such as LDL-C/HDL-C, total/HDL cholesterol, non-HDL cholesterol, and total cholesterol (χ(1)(2) = 407, 334, 204, and 105, respectively). Given apoB and apoA(1), the relationship with risk of LDL-C was reversed, and this reversal was strengthened by appropriate allowance for random measurement errors in two correlated variables. Given usual apoB, lower LDL-C (consistent with smaller LDL particles) was associated with higher risk (P < 0.0001). During the first 8 h after symptom onset HDL-C increased by about 10%, precluding reliable assessment of the joint relationship of apoA(1) and pre-onset HDL-C with risk in such retrospective case–control studies. CONCLUSION: Apolipoprotein ratios are more informative about risk than lipid fractions are. This suggests that, among lipoprotein particles of a particular type (LDL or HDL), some smaller and larger subtypes differ in their effects on risk. Direct measurements of even more specific subtypes of lipoprotein particles may be even more informative about risk.
format Text
id pubmed-2735728
institution National Center for Biotechnology Information
language English
publishDate 2009
publisher Oxford University Press
record_format MEDLINE/PubMed
spelling pubmed-27357282009-09-02 The joint effects of apolipoprotein B, apolipoprotein A(1), LDL cholesterol, and HDL cholesterol on risk: 3510 cases of acute myocardial infarction and 9805 controls† Parish, Sarah Peto, Richard Palmer, Alison Clarke, Robert Lewington, Sarah Offer, Alison Whitlock, Gary Clark, Sarah Youngman, Linda Sleight, Peter Collins, Rory Eur Heart J Clinical Research AIMS: Plasma levels of apolipoprotein B (apoB), the main surface protein on LDL particles, and LDL-C, the amount of cholesterol in those particles, are closely correlated and, considered separately, are positive risk factors. Plasma levels of apolipoprotein A(1), the main surface protein on HDL particles, and HDL-C, the amount of cholesterol in those particles, are also closely correlated with each other and, considered separately, are negative risk factors. The interdependence of these four risk factors is unclear. METHODS AND RESULTS: Case–control study among 3510 acute myocardial infarction patients (without prior vascular disease, diabetes, or statin use) in UK hospitals and 9805 controls. Relative risks (age, sex, smoking, and obesity-adjusted) were more strongly related to apoB than to LDL-C and, given apoB, more strongly negatively related to apoA(1) than to HDL-C. The ratio apoB/apoA(1) was uncorrelated with time since symptom onset in cases, was reproducible in samples collected a few years apart in controls (correlation 0.81), and encapsulated almost all the predictive power of these four measurements. Its effect was continuous, substantial throughout the UK normal range [relative risk, top vs. bottom decile of this ratio, 7.3 (95% CI 5.8–9.2)] and varied little with age. The ratio apoB/apoA(1) was substantially more informative about risk (χ(1)(2) = 550) than were commonly used measures such as LDL-C/HDL-C, total/HDL cholesterol, non-HDL cholesterol, and total cholesterol (χ(1)(2) = 407, 334, 204, and 105, respectively). Given apoB and apoA(1), the relationship with risk of LDL-C was reversed, and this reversal was strengthened by appropriate allowance for random measurement errors in two correlated variables. Given usual apoB, lower LDL-C (consistent with smaller LDL particles) was associated with higher risk (P < 0.0001). During the first 8 h after symptom onset HDL-C increased by about 10%, precluding reliable assessment of the joint relationship of apoA(1) and pre-onset HDL-C with risk in such retrospective case–control studies. CONCLUSION: Apolipoprotein ratios are more informative about risk than lipid fractions are. This suggests that, among lipoprotein particles of a particular type (LDL or HDL), some smaller and larger subtypes differ in their effects on risk. Direct measurements of even more specific subtypes of lipoprotein particles may be even more informative about risk. Oxford University Press 2009-09 2009-06-11 /pmc/articles/PMC2735728/ /pubmed/19520708 http://dx.doi.org/10.1093/eurheartj/ehp221 Text en Published on behalf of the European Society of Cardiology. All rights reserved. © The Author 2009. For permissions please email: journals.permissions@oxfordjournals.org http://creativecommons.org/licenses/by-nc/2.0/uk/ The online version of this article has been published under an open access model. Users are entitled to use, reproduce, disseminate, or display the open access version of this article for non-commercial purposes provided that the original authorship is properly and fully attributed; the Journal, Learned Society and Oxford University Press are attributed as the original place of publication with correct citation details given; if an article is subsequently reproduced or disseminated not in its entirety but only in part or as a derivative work this must be clearly indicated. For commercial re-use, please contact journals.permissions@oxfordjournals.org
spellingShingle Clinical Research
Parish, Sarah
Peto, Richard
Palmer, Alison
Clarke, Robert
Lewington, Sarah
Offer, Alison
Whitlock, Gary
Clark, Sarah
Youngman, Linda
Sleight, Peter
Collins, Rory
The joint effects of apolipoprotein B, apolipoprotein A(1), LDL cholesterol, and HDL cholesterol on risk: 3510 cases of acute myocardial infarction and 9805 controls†
title The joint effects of apolipoprotein B, apolipoprotein A(1), LDL cholesterol, and HDL cholesterol on risk: 3510 cases of acute myocardial infarction and 9805 controls†
title_full The joint effects of apolipoprotein B, apolipoprotein A(1), LDL cholesterol, and HDL cholesterol on risk: 3510 cases of acute myocardial infarction and 9805 controls†
title_fullStr The joint effects of apolipoprotein B, apolipoprotein A(1), LDL cholesterol, and HDL cholesterol on risk: 3510 cases of acute myocardial infarction and 9805 controls†
title_full_unstemmed The joint effects of apolipoprotein B, apolipoprotein A(1), LDL cholesterol, and HDL cholesterol on risk: 3510 cases of acute myocardial infarction and 9805 controls†
title_short The joint effects of apolipoprotein B, apolipoprotein A(1), LDL cholesterol, and HDL cholesterol on risk: 3510 cases of acute myocardial infarction and 9805 controls†
title_sort joint effects of apolipoprotein b, apolipoprotein a(1), ldl cholesterol, and hdl cholesterol on risk: 3510 cases of acute myocardial infarction and 9805 controls†
topic Clinical Research
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2735728/
https://www.ncbi.nlm.nih.gov/pubmed/19520708
http://dx.doi.org/10.1093/eurheartj/ehp221
work_keys_str_mv AT parishsarah thejointeffectsofapolipoproteinbapolipoproteina1ldlcholesterolandhdlcholesterolonrisk3510casesofacutemyocardialinfarctionand9805controls
AT petorichard thejointeffectsofapolipoproteinbapolipoproteina1ldlcholesterolandhdlcholesterolonrisk3510casesofacutemyocardialinfarctionand9805controls
AT palmeralison thejointeffectsofapolipoproteinbapolipoproteina1ldlcholesterolandhdlcholesterolonrisk3510casesofacutemyocardialinfarctionand9805controls
AT clarkerobert thejointeffectsofapolipoproteinbapolipoproteina1ldlcholesterolandhdlcholesterolonrisk3510casesofacutemyocardialinfarctionand9805controls
AT lewingtonsarah thejointeffectsofapolipoproteinbapolipoproteina1ldlcholesterolandhdlcholesterolonrisk3510casesofacutemyocardialinfarctionand9805controls
AT offeralison thejointeffectsofapolipoproteinbapolipoproteina1ldlcholesterolandhdlcholesterolonrisk3510casesofacutemyocardialinfarctionand9805controls
AT whitlockgary thejointeffectsofapolipoproteinbapolipoproteina1ldlcholesterolandhdlcholesterolonrisk3510casesofacutemyocardialinfarctionand9805controls
AT clarksarah thejointeffectsofapolipoproteinbapolipoproteina1ldlcholesterolandhdlcholesterolonrisk3510casesofacutemyocardialinfarctionand9805controls
AT youngmanlinda thejointeffectsofapolipoproteinbapolipoproteina1ldlcholesterolandhdlcholesterolonrisk3510casesofacutemyocardialinfarctionand9805controls
AT sleightpeter thejointeffectsofapolipoproteinbapolipoproteina1ldlcholesterolandhdlcholesterolonrisk3510casesofacutemyocardialinfarctionand9805controls
AT collinsrory thejointeffectsofapolipoproteinbapolipoproteina1ldlcholesterolandhdlcholesterolonrisk3510casesofacutemyocardialinfarctionand9805controls
AT parishsarah jointeffectsofapolipoproteinbapolipoproteina1ldlcholesterolandhdlcholesterolonrisk3510casesofacutemyocardialinfarctionand9805controls
AT petorichard jointeffectsofapolipoproteinbapolipoproteina1ldlcholesterolandhdlcholesterolonrisk3510casesofacutemyocardialinfarctionand9805controls
AT palmeralison jointeffectsofapolipoproteinbapolipoproteina1ldlcholesterolandhdlcholesterolonrisk3510casesofacutemyocardialinfarctionand9805controls
AT clarkerobert jointeffectsofapolipoproteinbapolipoproteina1ldlcholesterolandhdlcholesterolonrisk3510casesofacutemyocardialinfarctionand9805controls
AT lewingtonsarah jointeffectsofapolipoproteinbapolipoproteina1ldlcholesterolandhdlcholesterolonrisk3510casesofacutemyocardialinfarctionand9805controls
AT offeralison jointeffectsofapolipoproteinbapolipoproteina1ldlcholesterolandhdlcholesterolonrisk3510casesofacutemyocardialinfarctionand9805controls
AT whitlockgary jointeffectsofapolipoproteinbapolipoproteina1ldlcholesterolandhdlcholesterolonrisk3510casesofacutemyocardialinfarctionand9805controls
AT clarksarah jointeffectsofapolipoproteinbapolipoproteina1ldlcholesterolandhdlcholesterolonrisk3510casesofacutemyocardialinfarctionand9805controls
AT youngmanlinda jointeffectsofapolipoproteinbapolipoproteina1ldlcholesterolandhdlcholesterolonrisk3510casesofacutemyocardialinfarctionand9805controls
AT sleightpeter jointeffectsofapolipoproteinbapolipoproteina1ldlcholesterolandhdlcholesterolonrisk3510casesofacutemyocardialinfarctionand9805controls
AT collinsrory jointeffectsofapolipoproteinbapolipoproteina1ldlcholesterolandhdlcholesterolonrisk3510casesofacutemyocardialinfarctionand9805controls